Sfoglia per RIVISTA
BONE MARROW TRANSPLANTATION
Collezione AOU Alessandria
Items : 14
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). in Bone marrow transplantation / Bone Marrow Transplant. 2024 Aug;59(8):1084-1091. doi: 10.1038/s41409-024-02282-7. Epub 2024 Apr 25.
2024
AOU Alessandria
Kröger N; Robin M; McLornan DP; Kobbe G; Bethge W; Poiré X; Salmenniemi U; Saccardi R; Ladetto M; Dreger P; Passweg J; Onida F; Morozova E; Stelljes M; Hübel K; Scheid C; Müller LP; van Os M; Platzbecker U; Koster L; Iacobelli S; Franke GN; Niederwieser C;
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Mar;57(3):499-501. doi: 10.1038/s41409-021-01560-y. Epub 2022 Jan 10.
2022
AOU Alessandria
Beksac M; Yakoub-Agha I; Schönland S; Hayden PJ; Zuckerman T; Monaco F; Koster L; de Wreede L; Schroyens W; Sanz J; Ducastelle S; Teipel R; Koenecke C; Botella-Garcia C; Lenain P; Hänel M; van Doesum J; Minnema M; Rosinol L; Harel S; Passweg J; Finke J; Ceballos P; Gras L; Vincent L;
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Jun;57(6):949-958. doi: 10.1038/s41409-022-01626-5. Epub 2022 Apr 12.
2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Alessandria
Ciceri F; Grassi A; Bruno B; Rambaldi A; Vacca A; Vallisa D; Sacchi N; Oldani E; Masciulli A; Onida F; Palazzo G; Parma M; Tringali S; Martino M; Gheorghiu A; Girmenia C; Chiusolo P; Cupri A; Luppi M; Nozzoli C; Baronciani D; Casini M; Musso M; Grillo G; Carluccio P; Sorasio R; Cilloni D; Picardi A; Proia A; et alii...
Unrelated donor transplantation in aplastic anemia with a quadruple GVHD prophylaxis in Bone Marrow Transplantation
2022
AOU Città della Salute di Torino
AOU Alessandria
Giammarco S; Mordini N; Zallio F; Cavattoni I; Castagna L; Terruzzi E; Iori A; Chiusolo P; Metafuni E; Sorá F; Luca L; Limongiello MA; Innocenti I; Autore F; Galli E; Sica S; Bacigalupo A;
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Oct;56(10):2606-2609. doi: 10.1038/s41409-021-01391-x. Epub 2021 Jul 7.
2021
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
Tarella C; Rambaldi A; Castellino C; Gianni AM; Rigacci L; Chiappella A; Benedetti F; Nicoli P; Vitolo U; Ferreri AJM; Costa A; Patti C; Ferrero S; Rossi A; Barbui AM; Magni M; Ladetto M; Corradini P; Evangelista A; Devizzi L; Mian M; Cortelazzo S;
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Dec;56(12):3108. doi: 10.1038/s41409-021-01490-9.
2021
AOU Città della Salute di Torino
AOU Alessandria
Dreger P; Montoto S; Hayden PJ; Yakoub-Agha I; Vandenberghe E; Robinson S; Zallio F; Jindra P; Potter V; Mayer J; Orvain C; Bourhis JH; Wulf GG; Van Gorkom G; Kröger N; Schanz U; Gyan E; Sora F; Schianca FC; Passweg J; Beelen D; Choi G; Blaise D; Koster L; Schetelig J; Sellner L;
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. in Bone marrow transplantation / Bone Marrow Transplant. 2020 Dec;55(12):2335-2338. doi: 10.1038/s41409-020-0946-x. Epub 2020 May 22.
2020
AOU Città della Salute di Torino
AOU Alessandria
Dreger P; Montoto S; Yakoub-Agha I; Hayden PJ; Robinson S; Vandenberghe E; Zallio F; Potter V; Jindra P; Bourhis JH; Orvain C; Mayer J; Van Gorkom G; Wulf GG; Kröger N; Sora F; Blaise D; Beelen D; Schianca FC; Passweg J; Schanz U; Gyan E; Koster L; Choi G; Schetelig J; Sellner L;
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. in Bone marrow transplantation / Bone Marrow Transplant. 2020 Aug;55(8):1580-1587. doi: 10.1038/s41409-020-0855-z. Epub 2020 Mar 13.
2020
AOU Alessandria
Bacigalupo A; Angelucci E; Raiola AM; Varaldo R; Di Grazia C; Gualandi F; Benedetti E; Risitano A; Musso M; Zallio F; Ciceri F; Chiusolo P; Sica S; Rambaldi A; Bonifazi F; Parma M; Martino M; Onida F; Iori AP; Selleri C; Borghero C; Bertaina A; Prezioso L; Algeri M; Locatelli F;
Pain and anxiety management during bone marrow aspirates in italian transplant programs. A nationwide Survey on behalf of Gitmo Ng in Bone Marrow Transplantation
2020
AOU Alessandria
Gargiulo G; Orlando L; Cioce M; De Cecco V; Mentone C; Pesce A; Samarani E; Soave S; Bonifazi F; Ciceri F; Botti S;
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO). in Bone marrow transplantation / Bone Marrow Transplant. 2018 Jan;53(1):58-63. doi: 10.1038/bmt.2017.223. Epub 2017 Oct 30.
2018
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
Olivieri A; Bonifazi F; Bruno B; Chiarucci M; Stanghellini MTL; Vassallo E; Tecchio C; Skert C; Severino A; Raimondi R; Rovelli A; Santarone S; Pini M; Pastore D; Patriarca F; Onida F; Milone G; Micò MC; Marotta S; Iori AP; Guidi S; Fedele R; Faraci M; Falcioni S; Colombo AA; Facchini L; Cimminiello M; Cavattoni IM; Calore E; et alii...
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. in Bone marrow transplantation / Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.
2018
AOU Alessandria
AOU Novara
Di Nardo E; Saraceni F; Milone G; Pastore D; Specchia G; Lanza F; Codeluppi K; Mele G; Merli F; Capria S; Musto P; Marktel S; Mengarelli A; Ciceri F; Zallio F; Pini M; Moscato T; Martino M; Pioltelli PE; Piccirillo N; Sica S; Nassi L; Gaidano G; Farina L; Corradini P; Poiani M; Pascale SP; Chiarucci M; Nuccorini R; et alii...
Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma. in Bone marrow transplantation / Bone Marrow Transplant. 2017 Aug;52(8):1208-1211. doi: 10.1038/bmt.2017.99. Epub 2017 Jun 5.
2017
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
Bruno B; Busca A; Mordini N; Pini M; Vitolo U; Aydin S; Boccadoro M; Iovino G; Passera R; Maffini E; Dellacasa C; Sorasio R; Brunello L; Festuccia M; Zallio F; Giaccone L;
HLA-haploidentical allografting with high-dose posttransplant cyclophosphamide: Clinical outcomes and immune-reconstitution in Bone Marrow Transplantation
2015
AOU Città della Salute di Torino
AOU Alessandria
Busca A; Maffini E; Ferrando F; Dellacasa C; Pulito R; Saraci E; Giaccone L; Boccadoro M; Omedè P; Bruno B;
High-dose rituximab in the conditioning regimen before allogeneic stem cell transplantation for relapsed B-cell lymphomas is associated with reduced gvhd-related deaths, but did not improve disease control in Bone Marrow Transplantation
2014
AOU Città della Salute di Torino
AOU Alessandria
Dodero A; Spina F; Sarina B; Carniti C; Patriarca F; Carella AM; Levis A; Bosi A; Falda M; Di Raimondo F; Di Bartolomeo P; Dalto S; Bacigalupo A; Rambaldi A; Corradini P; Giaccone L; Brunello L; Festuccia M; Gilestro M; Maffini E; Ferrando F; Talamo E; Passera R; Boccadoro M; Omedè P; Bruno B;